Geron unloads its stem cell coffers to BioTime in stock deal – FierceBiotech
|
Geron unloads its stem cell coffers to BioTime in stock deal
FierceBiotech After more than a year of not-so-secret negotiations, Geron ($GERN) has finally auctioned off its long-stalled embryonic stem cell pipeline, handing it over to a newfangled BioTime ($BTX) subsidiary in exchange for shares. Under the deal, BioTime gets … Geron Completes Divestiture of Stem Cell AssetsMarketWatch BIOTIME, INC. : Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc …4-traders (press release) |
